Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines

被引：58
作者：
Rim, Chai Hong [1 ]
Seong, Jinsil [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, 50 Yonsei Ro, Seoul 03722, South Korea
来源：
RADIATION ONCOLOGY JOURNAL | 2016年 / 34卷 / 03期
关键词：
Radiotherapy; Hepatocellular carcinoma; Practice guideline;
D O I：
10.3857/roj.2016.01970
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In oncologic practice, treatment guidelines provide appropriate treatment strategies based on evidence. Currently, many guidelines are used, including those of the European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL-EORTC), National Comprehensive Cancer Network (NCCN), Asia-Pacific Primary Liver Cancer Expert (APPLE), and Korean Liver Cancer Study Group and National Cancer Centre (KLCSG-NCC). Although radiotherapy is commonly used in clinical practice, some guidelines do not accept it as a standard treatment modality. In this review, we will investigate the clinical practice guidelines currently used, and discuss the application of radiotherapy.
引用
收藏
页码：160 / 167
页数：8
相关论文
共 46 条
  • [1] GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
    Andrews, Jeff
    Guyatt, Gordon
    Oxman, Andrew D.
    Alderson, Phil
    Dahm, Philipp
    Falck-Ytter, Yngve
    Nasser, Mona
    Meerpohl, Joerg
    Post, Piet N.
    Kunz, Regina
    Brozek, Jan
    Vist, Gunn
    Rind, David
    Akl, Elie A.
    Schuenemann, Holger J.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (07) : 719 - 725
  • [2] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [3] High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial
    Bush, DA
    Hillebrand, DJ
    Slater, JM
    Slater, JD
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S189 - S193
  • [4] Phase 2 Study of Combined Sorafenib and Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma
    Chen, Shang-Wen
    Lin, Li-Ching
    Kuo, Yu-Cheng
    Liang, Ji-An
    Kuo, Chia-Chun
    Chiou, Jeng-Fong
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (05): : 1041 - 1047
  • [5] Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease
    Cheng, JCH
    Wu, JK
    Huang, CM
    Liu, HS
    Huang, DY
    Tsai, SY
    Cheng, SH
    Jian, JJM
    Huang, AT
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 229 - 234
  • [6] Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
    Choi, Hye Jin
    Cho, Byung Chul
    Sohn, Joo Hyuk
    Shin, Sang Jun
    Kim, Se Hyun
    Kim, Joo Hang
    Yoo, Nae Choon
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) : 307 - 313
  • [7] The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
    Cillo, U
    Bassanello, M
    Vitale, A
    Grigoletto, FA
    Burra, P
    Fagiuoli, S
    D'Amico, F
    Ciarleglio, FA
    Boccagni, P
    Brolese, A
    Zanus, G
    D'Amico, DF
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (01) : 124 - 131
  • [8] Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
    Dawson, LA
    McGinn, CJ
    Normolle, D
    Ten Haken, RK
    Walker, S
    Ensminger, W
    Lawrence, TS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2210 - 2218
  • [9] DeLaney TF, 2011, FRONT RADIAT THER ON, V43, P465, DOI 10.1159/000322511
  • [10] EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (05) : 599 - 641
12345